유전자 발현 분석 시장 예측(-2030년) : 제품별, 기술별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Gene Expression Analysis Market is accounted for $4.9 billion in 2023 and is expected to reach $10.0 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Gene expression analysis refers to the study of the way genes are transcribed into RNA and translated into proteins, or the functional products they encode. It involves the measurement of the activity of genes in a particular cell, tissue, or organism under specific conditions. The analysis provides insights into wh Gene expression analysis for understanding the molecular mechanisms underlying various biological processes, including development, differentiation, response to stimuli, and diseases. By examining the patterns of gene expression, researchers can identify key genes involved in specific pathways, determine how genes are regulated, and gain insights into the molecular basis of diseases.

According to a 2016 survey conducted by the Federation of Indian Chambers of Commerce & Industry (FICCI), India faces an acute shortage of nearly 80% of Doctorate and Post Doctorate Scientists, a 20% shortage of people with a Master's degree, and a production staff shortage of 18% in the biotechnology sector.

Market Dynamics:

Driver:

Growing adoption of personalized medicine

The market is witnessing a surge in the adoption of personalized medicine, with a growing emphasis on tailoring treatments based on individual genetic profiles. This trend is driven by advancements in genomic research and technology, allowing for more precise analysis of gene expression patterns. As healthcare providers increasingly recognize the value of personalized approaches, the market is expected to expand further, offering innovative solutions for tailored therapies and diagnostics.

Restraint:

Shortage of trained professionals

The demand for skilled experts in interpreting and analyzing gene expression data far exceeds the current workforce supply. This shortage poses a significant challenge to harnessing the full potential of genomics in understanding diseases and developing targeted therapies. Addressing this gap through education and training initiatives is crucial to propel the field forward and unlock the transformative capabilities of gene expression analysis in healthcare and life sciences. The market faces a critical shortage of trained professionals, hindering advancements in genomic research and diagnostics.

Opportunity:

Rapid technological advancement

Innovations in high-throughput sequencing, single-cell analysis, and bioinformatics have propelled gene expression analysis to unprecedented levels of accuracy and efficiency. The continuous evolution of gene expression analysis technologies holds immense promise for advancing precision medicine and transforming our understanding of genetic regulation. The market has witnessed rapid technological advancement, revolutionizing the understanding of cellular function.

Threat:

High cost of the instruments

The sophisticated technology and specialized equipment required for gene expression analysis contribute to the elevated prices. This financial barrier may limit smaller laboratories or research facilities from fully engaging in comprehensive gene expression studies, potentially impacting the inclusivity and progress of scientific advancements in this field. Addressing cost concerns is crucial for fostering broader participation and innovation in gene expression analysis research. High cost of instruments is the factor hindering the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the market. Increased focus on understanding the virus's molecular mechanisms has driven demand for gene expression analysis tools. However, disruptions in supply chains, laboratory closures, and reduced funding for research have posed challenges. The market has witnessed both surges and declines, with shifts in priorities towards infectious disease research. Adapting to remote work and digital solutions has become crucial for companies in this sector to navigate the uncertainties and maintain momentum.

The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period

The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period. This enables amplification of specific DNA sequences, facilitating gene expression analysis with high sensitivity and precision. Increasing demand for personalized medicine and advancements in genomics contribute to market expansion. Key players are investing in innovative PCR technologies, enhancing product portfolios. The market is poised for continuous growth, propelled by the expanding applications of PCR in diagnostics, therapeutics, and research endeavors.

The drug discovery & development segment is expected to have the highest CAGR during the forecast period

The drug discovery & development segment is expected to have the highest CAGR during the forecast period. Leveraging cutting-edge technologies, researchers analyze gene expression patterns to identify potential drug targets and biomarkers. This sophisticated approach enables a deeper understanding of disease mechanisms, aiding in the development of innovative therapeutics. With continuous advancements in genomics and bioinformatics, the market remains integral to shaping the future of precision medicine and personalized treatment strategies.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region showcases a strong demand for gene expression profiling tools, including microarrays and next-generation sequencing platforms. Key factors contributing to market growth include increasing research activities in genomics, rising prevalence of chronic diseases, and a supportive regulatory environment. Collaborations between research institutions and industry players further propel innovation in gene expression analysis, ensuring a flourishing market landscape.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the collaborations between academic institutions and biotechnology companies. . Key players in the region are actively developing innovative solutions for gene expression analysis, contributing to a dynamic and competitive landscape. The market's upward trajectory is expected to continue as the region becomes a prominent hub for genomics and molecular biology research.

Key players in the market

Some of the key players in Gene Expression Analysis market include Agilent Technologies, GE Healthcare, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Luminex Corp., Quest Diagnostics, Inc., PerkinElmer, Inc., Takara Bio, Inc., Catalent Inc., Promega Corp., Danaher Corp., QIAGEN, Novogene Corporation and Oxford Nanopore Technologies.

Key Developments:

In August 2023, The MinION MK1C, a new sequencer designed to be more reasonably priced and available to researchers, has been launched, according to an announcement from Oxford Nanopore Technologies. Gene expression analysis and RNA and DNA sequencing can both be done using the MinION MK1C.

In January 2023, The bioinformatics division of QIAGEN, QIAGEN Digital Insights (QDI), has just launched the QIAGEN CLC Genomics Workbench Premium, which eliminates the data-analysis bottleneck of next-generation sequencing.

Products Covered:

• DNA Chips
• Kits & Reagents
• Services
• Other Products

Technologies Covered:

• Next Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Microarrays
• Other Technologies

Applications Covered:

• Biotech & Microbiology
• Clinical Diagnostics
• Drug Discovery & Development
• Other Applications

End Users Covered:

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Gene Expression Analysis Market, By Product

• 5.1 Introduction
• 5.2 DNA Chips
• 5.3 Kits & Reagents
• 5.4 Services
• 5.5 Other Products

6 Global Gene Expression Analysis Market, By Technology

• 6.1 Introduction
• 6.2 Next Generation Sequencing (NGS)
• 6.3 Polymerase Chain Reaction (PCR)
• 6.4 Microarrays
• 6.5 Other Technologies

7 Global Gene Expression Analysis Market, By Application

• 7.1 Introduction
• 7.2 Biotech & Microbiology
• 7.3 Clinical Diagnostics
• 7.4 Drug Discovery & Development
• 7.5 Other Applications

8 Global Gene Expression Analysis Market, By End User

• 8.1 Introduction
• 8.2 Academic and Research Institutes
• 8.3 Pharmaceutical and Biotechnology Companies
• 8.4 Other End Users

9 Global Gene Expression Analysis Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Agilent Technologies
• 11.2 GE Healthcare
• 11.3 Illumina, Inc.
• 11.4 Thermo Fisher Scientific, Inc.
• 11.5 Bio-Rad Laboratories
• 11.6 F. Hoffmann-La Roche Ltd.
• 11.7 Luminex Corp.
• 11.8 Quest Diagnostics, Inc.
• 11.9 PerkinElmer, Inc.
• 11.10 Takara Bio, Inc.
• 11.11 Catalent Inc.
• 11.12 Promega Corp.
• 11.13 Danaher Corp.
• 11.14 QIAGEN
• 11.15 Novogene Corporation
• 11.16 Oxford Nanopore Technologies